In CAD, P2Y12 inhibitor vs. aspirin monotherapy reduces a composite CV outcome without increasing major bleeding.
Publication
, Journal Article
Tannu, M; Newby, LK
Published in: Ann Intern Med
November 2023
Gragnano F, Cao D, Pirondini L, et al; PANTHER Collaboration. P2Y12 inhibitor or aspirin monotherapy for secondary prevention of coronary events. J Am Coll Cardiol. 2023;82:89-105. 37407118.
Duke Scholars
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
November 2023
Volume
176
Issue
11
Start / End Page
JC123
Location
United States
Related Subject Headings
- Treatment Outcome
- Purinergic P2Y Receptor Antagonists
- Platelet Aggregation Inhibitors
- Percutaneous Coronary Intervention
- Humans
- Hemorrhage
- General & Internal Medicine
- Drug Therapy, Combination
- Aspirin
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Tannu, M., & Newby, L. K. (2023). In CAD, P2Y12 inhibitor vs. aspirin monotherapy reduces a composite CV outcome without increasing major bleeding. Ann Intern Med, 176(11), JC123. https://doi.org/10.7326/J23-0090
Tannu, Manasi, and L Kristin Newby. “In CAD, P2Y12 inhibitor vs. aspirin monotherapy reduces a composite CV outcome without increasing major bleeding.” Ann Intern Med 176, no. 11 (November 2023): JC123. https://doi.org/10.7326/J23-0090.
Tannu M, Newby LK. In CAD, P2Y12 inhibitor vs. aspirin monotherapy reduces a composite CV outcome without increasing major bleeding. Ann Intern Med. 2023 Nov;176(11):JC123.
Tannu, Manasi, and L. Kristin Newby. “In CAD, P2Y12 inhibitor vs. aspirin monotherapy reduces a composite CV outcome without increasing major bleeding.” Ann Intern Med, vol. 176, no. 11, Nov. 2023, p. JC123. Pubmed, doi:10.7326/J23-0090.
Tannu M, Newby LK. In CAD, P2Y12 inhibitor vs. aspirin monotherapy reduces a composite CV outcome without increasing major bleeding. Ann Intern Med. 2023 Nov;176(11):JC123.
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
November 2023
Volume
176
Issue
11
Start / End Page
JC123
Location
United States
Related Subject Headings
- Treatment Outcome
- Purinergic P2Y Receptor Antagonists
- Platelet Aggregation Inhibitors
- Percutaneous Coronary Intervention
- Humans
- Hemorrhage
- General & Internal Medicine
- Drug Therapy, Combination
- Aspirin
- 3202 Clinical sciences